中华护理杂志 ›› 2021, Vol. 56 ›› Issue (10): 1595-1600.DOI: 10.3761/j.issn.0254-1769.2021.10.025

• 综述 • 上一篇    

造血干细胞移植患者肌少症管理的研究进展

叶梦华(),徐敏()   

  1. 310053 杭州市 浙江中医药大学护理学院(叶梦华);浙江中医药大学附属第一医院医院管理办公室(徐敏)
  • 收稿日期:2021-04-19 出版日期:2021-10-15 发布日期:2021-10-19
  • 通讯作者: 徐敏
  • 作者简介:叶梦华:女,本科(硕士在读),护士,E-mail: 1947332606@qq.com
  • 基金资助:
    浙江省中医药优秀青年人才基金项目(2021ZQ038)

Research progress of sarcopenia management in patients with hematopoietic stem cell transplantation

YE Menghua(),XU Min()   

  • Received:2021-04-19 Online:2021-10-15 Published:2021-10-19
  • Contact: Min XU

摘要:

造血干细胞移植是目前治疗恶性及非恶性难治性血液病的有效方法。肌少症是造血干细胞移植患者严重的并发症之一,影响患者的康复及预后。该文介绍了肌少症的筛查与评估方法,综述了造血干细胞移植患者肌少症的危险因素及常用的非药物干预方法,并提出相关管理建议,旨在为临床医护人员针对造血干细胞患者进行肌少症的前期预防、早期发现、及时干预提供参考。

关键词: 造血干细胞移植, 肌少症, 危险因素, 非药物干预, 综述, 护理

Abstract:

Hematopoietic stem cell transplantation(HSCT) is an effective therapy for the treatment of malignant and non-malignant refractory hematopathy. Sarcopenia is one of the serious complications in HSCT patients,which affects the recovery and prognosis of the patients. This article reviews the screening and assessment of sarcopenia,analyses the risk factors of sarcopenia in HSCT patients and the current common non-pharmacological interventions,then makes recommendations for sarcopenia management,aiming to provide references for clinical medical staff to carry out early prevention,early detection and timely intervention for such patients.

Key words: Hematopoietic Stem Cell Transplantation, Sarcopenia, Risk Factors, Non-Pharmacological Interventions, Review, Nursing Care